US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.8100
  • -0.0300-1.63%
Trading Nov 7 10:34 ET
11.13MMarket Cap-632P/E (TTM)

Aytu BioPharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Total revenue
-24.58%81M
-41.51%17.98M
-20.85%17.99M
-12.73%22.93M
-20.09%22.1M
11.10%107.4M
11.96%30.73M
-6.06%22.73M
13.64%26.28M
26.30%27.66M
Operating revenue
-24.58%81M
-41.51%17.98M
-20.85%17.99M
-12.73%22.93M
-20.09%22.1M
11.10%107.4M
11.96%30.73M
-6.06%22.73M
13.64%26.28M
30.82%27.66M
Cost of revenue
-35.20%26.42M
-50.12%6.07M
-36.94%6.3M
-25.09%6.73M
-23.98%7.32M
-8.15%40.77M
-3.47%12.17M
-13.23%9.99M
-17.00%8.99M
1.93%9.62M
Gross profit
-18.08%54.59M
-35.87%11.91M
-8.24%11.69M
-6.30%16.2M
-18.01%14.78M
27.44%66.63M
25.08%18.56M
0.45%12.74M
40.60%17.29M
44.77%18.03M
Operating expense
-27.21%57.48M
-14.73%13.44M
-36.86%13.91M
-35.59%13.84M
-17.26%16.29M
-10.66%78.96M
-28.21%15.76M
-0.50%22.04M
-8.93%21.49M
-4.91%19.69M
Selling and administrative expenses
-29.40%49.47M
-21.33%11.09M
-39.99%11.99M
-35.33%12.02M
-17.48%14.38M
0.28%70.08M
-18.97%14.1M
15.10%19.98M
5.48%18.58M
-0.51%17.42M
-Selling and marketing expense
-34.96%26.96M
-19.68%6.41M
-48.85%6.55M
-37.73%6.58M
-26.53%7.42M
7.06%41.45M
-20.28%7.98M
31.42%12.8M
9.32%10.56M
8.66%10.1M
-General and administrative expense
-21.36%22.51M
-23.49%4.68M
-24.17%5.44M
-32.17%5.44M
-5.00%6.96M
-8.14%28.63M
-17.19%6.11M
-5.76%7.18M
0.82%8.02M
-10.88%7.32M
Research and development costs
-31.84%2.79M
124.52%1.04M
-27.69%619K
-69.36%524K
-43.23%604K
-67.66%4.1M
-85.71%465K
-73.92%856K
-61.79%1.71M
-35.59%1.06M
Depreciation amortization depletion
8.86%5.21M
9.04%1.3M
8.76%1.3M
8.51%1.3M
9.11%1.31M
-18.07%4.79M
-7.94%1.2M
-20.35%1.2M
-20.40%1.2M
-22.12%1.2M
-Depreciation and amortization
8.86%5.21M
9.04%1.3M
8.76%1.3M
8.51%1.3M
9.11%1.31M
-18.07%4.79M
-7.94%1.2M
-20.35%1.2M
-20.40%1.2M
-22.12%1.2M
Operating profit
76.57%-2.89M
-154.43%-1.53M
76.11%-2.22M
156.38%2.36M
9.01%-1.5M
65.85%-12.33M
139.54%2.81M
1.77%-9.29M
62.87%-4.19M
79.95%-1.65M
Net non-operating interest income expense
3.45%-4.79M
-4.96M
Non-operating interest expense
-3.45%4.79M
----
----
----
----
--4.96M
----
----
----
----
Other net income (expense)
-2,753.53%-6.4M
891.75%2.4M
-120.17%-422K
29.76%-1.76M
-794.96%-6.62M
100.33%241K
96.63%-303K
104.77%2.09M
-872.76%-2.5M
104.83%952K
Gain on sale of security
-183.54%-4M
206.48%1.46M
-60.47%1.02M
-141.13%-577K
-369.60%-5.91M
198.63%4.79M
-185.24%-1.37M
36,857.14%2.57M
--1.4M
--2.19M
Special income (charges)
37.52%-2.96M
-2.84%-2.72M
-133.24%-244K
--0
--0
93.57%-4.74M
73.17%-2.64M
101.67%734K
---2.68M
99.21%-155K
-Less:Restructuring and merger&acquisition
344.07%2.37M
556.13%2.12M
133.24%244K
--0
--0
41.45%-969K
52.01%-465K
38.94%-734K
--75K
-29.22%155K
-Less:Impairment of capital assets
----
----
--0
----
----
----
----
--0
----
----
-Less:Other special charges
--594K
----
----
----
----
----
----
----
----
----
-Write off
--0
----
----
--0
----
-40.92%5.71M
----
----
--2.6M
----
Other non- operating income (expenses)
208.70%568K
-1.62%3.65M
1.65%-1.2M
3.99%-1.18M
34.59%-709K
124.31%184K
--3.71M
---1.22M
-377.82%-1.23M
-2,610.00%-1.08M
Income before tax
17.45%-14.08M
-59.63%-3.92M
63.31%-2.64M
109.08%608K
-1,058.35%-8.12M
84.34%-17.05M
84.73%-2.46M
86.49%-7.2M
42.06%-6.69M
97.49%-701K
Income tax
1.77M
695K
245K
828K
0
0
0
0
0
0
Net income
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
97.48%-701K
Net income continuous Operations
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
97.48%-701K
Minority interest income
Net income attributable to the parent company
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
97.48%-701K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
97.48%-701K
Basic earnings per share
44.03%-2.86
-38.98%-0.82
73.06%-0.52
98.14%-0.04
-428.57%-1.48
93.10%-5.11
93.98%-0.59
94.62%-1.93
75.40%-2.15
99.94%-0.28
Diluted earnings per share
44.03%-2.86
-38.98%-0.82
73.06%-0.52
98.14%-0.04
-428.57%-1.48
93.10%-5.11
93.98%-0.59
94.62%-1.93
75.40%-2.15
99.94%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Total revenue -24.58%81M-41.51%17.98M-20.85%17.99M-12.73%22.93M-20.09%22.1M11.10%107.4M11.96%30.73M-6.06%22.73M13.64%26.28M26.30%27.66M
Operating revenue -24.58%81M-41.51%17.98M-20.85%17.99M-12.73%22.93M-20.09%22.1M11.10%107.4M11.96%30.73M-6.06%22.73M13.64%26.28M30.82%27.66M
Cost of revenue -35.20%26.42M-50.12%6.07M-36.94%6.3M-25.09%6.73M-23.98%7.32M-8.15%40.77M-3.47%12.17M-13.23%9.99M-17.00%8.99M1.93%9.62M
Gross profit -18.08%54.59M-35.87%11.91M-8.24%11.69M-6.30%16.2M-18.01%14.78M27.44%66.63M25.08%18.56M0.45%12.74M40.60%17.29M44.77%18.03M
Operating expense -27.21%57.48M-14.73%13.44M-36.86%13.91M-35.59%13.84M-17.26%16.29M-10.66%78.96M-28.21%15.76M-0.50%22.04M-8.93%21.49M-4.91%19.69M
Selling and administrative expenses -29.40%49.47M-21.33%11.09M-39.99%11.99M-35.33%12.02M-17.48%14.38M0.28%70.08M-18.97%14.1M15.10%19.98M5.48%18.58M-0.51%17.42M
-Selling and marketing expense -34.96%26.96M-19.68%6.41M-48.85%6.55M-37.73%6.58M-26.53%7.42M7.06%41.45M-20.28%7.98M31.42%12.8M9.32%10.56M8.66%10.1M
-General and administrative expense -21.36%22.51M-23.49%4.68M-24.17%5.44M-32.17%5.44M-5.00%6.96M-8.14%28.63M-17.19%6.11M-5.76%7.18M0.82%8.02M-10.88%7.32M
Research and development costs -31.84%2.79M124.52%1.04M-27.69%619K-69.36%524K-43.23%604K-67.66%4.1M-85.71%465K-73.92%856K-61.79%1.71M-35.59%1.06M
Depreciation amortization depletion 8.86%5.21M9.04%1.3M8.76%1.3M8.51%1.3M9.11%1.31M-18.07%4.79M-7.94%1.2M-20.35%1.2M-20.40%1.2M-22.12%1.2M
-Depreciation and amortization 8.86%5.21M9.04%1.3M8.76%1.3M8.51%1.3M9.11%1.31M-18.07%4.79M-7.94%1.2M-20.35%1.2M-20.40%1.2M-22.12%1.2M
Operating profit 76.57%-2.89M-154.43%-1.53M76.11%-2.22M156.38%2.36M9.01%-1.5M65.85%-12.33M139.54%2.81M1.77%-9.29M62.87%-4.19M79.95%-1.65M
Net non-operating interest income expense 3.45%-4.79M-4.96M
Non-operating interest expense -3.45%4.79M------------------4.96M----------------
Other net income (expense) -2,753.53%-6.4M891.75%2.4M-120.17%-422K29.76%-1.76M-794.96%-6.62M100.33%241K96.63%-303K104.77%2.09M-872.76%-2.5M104.83%952K
Gain on sale of security -183.54%-4M206.48%1.46M-60.47%1.02M-141.13%-577K-369.60%-5.91M198.63%4.79M-185.24%-1.37M36,857.14%2.57M--1.4M--2.19M
Special income (charges) 37.52%-2.96M-2.84%-2.72M-133.24%-244K--0--093.57%-4.74M73.17%-2.64M101.67%734K---2.68M99.21%-155K
-Less:Restructuring and merger&acquisition 344.07%2.37M556.13%2.12M133.24%244K--0--041.45%-969K52.01%-465K38.94%-734K--75K-29.22%155K
-Less:Impairment of capital assets ----------0------------------0--------
-Less:Other special charges --594K------------------------------------
-Write off --0----------0-----40.92%5.71M----------2.6M----
Other non- operating income (expenses) 208.70%568K-1.62%3.65M1.65%-1.2M3.99%-1.18M34.59%-709K124.31%184K--3.71M---1.22M-377.82%-1.23M-2,610.00%-1.08M
Income before tax 17.45%-14.08M-59.63%-3.92M63.31%-2.64M109.08%608K-1,058.35%-8.12M84.34%-17.05M84.73%-2.46M86.49%-7.2M42.06%-6.69M97.49%-701K
Income tax 1.77M695K245K828K000000
Net income 7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M97.48%-701K
Net income continuous Operations 7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M97.48%-701K
Minority interest income
Net income attributable to the parent company 7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M97.48%-701K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M97.48%-701K
Basic earnings per share 44.03%-2.86-38.98%-0.8273.06%-0.5298.14%-0.04-428.57%-1.4893.10%-5.1193.98%-0.5994.62%-1.9375.40%-2.1599.94%-0.28
Diluted earnings per share 44.03%-2.86-38.98%-0.8273.06%-0.5298.14%-0.04-428.57%-1.4893.10%-5.1193.98%-0.5994.62%-1.9375.40%-2.1599.94%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data